Co-Authors
This is a "connection" page, showing publications co-authored by Woo Kim and Ji Noh.
Connection Strength
9.240
-
Risk factors for SARS-CoV-2 transmission in non-household clusters. J Infect. 2021 08; 83(2):e22-e24.
Score: 0.950
-
Safe hospital preparedness in the era of COVID-19: The Swiss cheese model. Int J Infect Dis. 2020 Sep; 98:294-296.
Score: 0.890
-
Social Distancing against COVID-19: Implication for the Control of Influenza. J Korean Med Sci. 2020 May 18; 35(19):e182.
Score: 0.883
-
Randomized, single-blind, active-controlled phase I clinical trial to evaluate the immunogenicity and safety of GC3114 (high-dose, quadrivalent influenza vaccine) in healthy adults. Vaccine. 2019 08 23; 37(36):5171-5176.
Score: 0.835
-
Significant circulation of influenza B viruses mismatching the recommended vaccine-lineage in South Korea, 2007-2014. Vaccine. 2018 08 23; 36(35):5304-5308.
Score: 0.778
-
Interim estimates of the effectiveness of the influenza vaccine against A(H3N2) influenza in adults in South Korea, 2016-2017 season. PLoS One. 2017; 12(5):e0178010.
Score: 0.718
-
Laboratory surveillance of influenza-like illness in seven teaching hospitals, South Korea: 2011-2012 season. PLoS One. 2013; 8(5):e64295.
Score: 0.544
-
Longitudinal Assessment of Antisevere Acute Respiratory Syndrome Coronavirus 2 Immune Responses for Six Months Based on the Clinical Severity of Coronavirus Disease 2019. J Infect Dis. 2021 09 01; 224(5):754-763.
Score: 0.241
-
Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination. J Korean Med Sci. 2021 Aug 30; 36(34):e245.
Score: 0.241
-
How lessons learned from the 2015 Middle East respiratory syndrome outbreak affected the response to coronavirus disease 2019 in the Republic of Korea. Korean J Intern Med. 2021 03; 36(2):271-285.
Score: 0.232
-
Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea. J Korean Med Sci. 2020 Aug 24; 35(33):e311.
Score: 0.225
-
Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva. J Korean Med Sci. 2020 May 25; 35(20):e195.
Score: 0.221
-
Asymptomatic infection and atypical manifestations of COVID-19: Comparison of viral shedding duration. J Infect. 2020 11; 81(5):816-846.
Score: 0.221
-
Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in = 50-year-old adults. BMC Infect Dis. 2018 Dec 05; 18(1):628.
Score: 0.200
-
Safety and Effectiveness of Peramivir in Korean Adult Influenza Patients: Prospective Observational Study Based on Post-Marketing Surveillance Data. J Korean Med Sci. 2018 Aug 06; 33(32):e212.
Score: 0.193
-
Molecular genetic characteristics of influenza A virus clinically isolated during 2011-2016 influenza seasons in Korea. Influenza Other Respir Viruses. 2018 07; 12(4):497-507.
Score: 0.190
-
Hospital-based Influenza Morbidity and Mortality (HIMM) Surveillance for A/H7N9 Influenza Virus Infection in Returning Travelers. J Korean Med Sci. 2018 Feb 12; 33(7):e49.
Score: 0.189
-
Effects of influenza immunization on pneumonia in the elderly. Hum Vaccin Immunother. 2018 03 04; 14(3):744-749.
Score: 0.187
-
Seroprevalence and disease burden of acute hepatitis A in adult population in South Korea. PLoS One. 2017; 12(10):e0186257.
Score: 0.185
-
Humoral and Cellular Immunogenicity Induced by Avian Influenza A (H7N9) DNA Vaccine in Mice. Infect Chemother. 2017 Jun; 49(2):117-122.
Score: 0.180
-
Campylobacter jejuni Bacteremia in a Liver Cirrhosis Patient and Review of Literature: A Case Study. Infect Chemother. 2017 Sep; 49(3):230-235.
Score: 0.179
-
Immunogenicity and safety of a cell culture-derived inactivated quadrivalent influenza vaccine (NBP607-QIV): A randomized, double-blind, multi-center, phase III clinical trial in adults and elderly subjects. Hum Vaccin Immunother. 2017 07 03; 13(7):1653-1660.
Score: 0.178
-
Viral Shedding and Environmental Cleaning in Middle East Respiratory Syndrome Coronavirus Infection. Infect Chemother. 2015 Dec; 47(4):252-5.
Score: 0.163
-
Early Safety Monitoring of COVID-19 Vaccines in Healthcare Workers. J Korean Med Sci. 2021 Apr 19; 36(15):e110.
Score: 0.059
-
Comparison of the second and third waves of the COVID-19 pandemic in South Korea: Importance of early public health intervention. Int J Infect Dis. 2021 Mar; 104:742-745.
Score: 0.058
-
Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study. Int J Infect Dis. 2021 Jan; 102:275-281.
Score: 0.057
-
Coronavirus Disease 2019 Outbreak at Nightclubs and Distribution Centers after Easing Social Distancing: Vulnerable Points of Infection. J Korean Med Sci. 2020 Jul 13; 35(27):e247.
Score: 0.056
-
Pneumonitis and concomitant bacterial pneumonia in patients receiving pembrolizumab treatment: Three case reports and literature review. Medicine (Baltimore). 2019 Jun; 98(25):e16158.
Score: 0.052
-
Molecular Epidemiology of Human Adenovirus-Associated Febrile Respiratory Illness in Soldiers, South Korea1. Emerg Infect Dis. 2018 07; 24(7):1221-1227.
Score: 0.048
-
Cost-effectiveness of pneumococcal vaccination strategies for the elderly in Korea. PLoS One. 2017; 12(5):e0177342.
Score: 0.045
-
Phylogenetic relationships of the HA and NA genes between vaccine and seasonal influenza A(H3N2) strains in Korea. PLoS One. 2017; 12(3):e0172059.
Score: 0.044